Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function

Detalhes bibliográficos
Autor(a) principal: Fernandes, Fernanda B. [UNIFESP]
Data de Publicação: 2008
Outros Autores: Plavnik, Frida L. [UNIFESP], Teixeira, Andressa M. S. [UNIFESP], Christofalo, Dejaldo M. J. [UNIFESP], Ajzen, Sergio A. [UNIFESP], Higa, Elisa M. S. [UNIFESP], Ronchi, Fernanda A. [UNIFESP], Sesso, Ricardo C. C. [UNIFESP], Casarini, Dulce E. [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/30750
http://dx.doi.org/10.2119/2007-00112.Fernandes
Resumo: The aim of this study was to investigate the association between urinary 90 kDa N-domain Angiotensin I-converting enzyme (ACE) form with C-reactive protein (CRP) and homocysteine plasma levels (Hcy), urinary nitric oxide (NOu), and endothelial function (EF) in normotensive subjects. Forty healthy subjects were evaluated through brachial Doppler US to test the response to reactive hyperemia and a panel of blood tests to determine CRP and Hcy levels, NOu, and urinary ACE. They were divided into groups according to the presence (ACE90+) or absence (ACE90-) of the 90 kDa ACE, the presence (FH+) or absence (FH-) of family history of hypertension, and the presence or absence of these two variables FH+/ACE90+ and FH-/ACE90-. We found an impaired endothelial dilatation in subjects who presented the 90 kDa N-domain ACE as follows: 11.4% +/- 5.3% in ACE90+ compared with 17.6% +/- 7.1% in ACE90- group and 12.4% +/- 5.6% in FH+/ACE90+ compared with 17.7% +/- 6.2% in FH-/ACE90- group, P < 0.05. Hcy and CRP levels were statistically significantly lower in FH+/ACE90+ than in FH-/ACE90- group, as follows: 10.0 +/- 2.3 mu M compared with 12.7 +/- 1.5 mu M, and 1.3 +/- 1.8 mg/L compared with 3.6 +/- 2.0 mg/L, respectively. A correlation between flow-mediated dilatation (FMD) and CRP, Hcy, and NOu levels was not found. Our study suggests a reduction in the basal NO production confirmed by NOu analysis in subjects with the 90 kDa N-domain ACE isoform alone or associated with a family history of hypertension, Our data suggest that the presence of the 90 kDa N-domain ACE itself may have a negative impact on flow-mediated dilatation stimulated by reactive hyperemia.
id UFSP_3a257f1bc78fa149713ee88f5997eca9
oai_identifier_str oai:repositorio.unifesp.br:11600/30750
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Fernandes, Fernanda B. [UNIFESP]Plavnik, Frida L. [UNIFESP]Teixeira, Andressa M. S. [UNIFESP]Christofalo, Dejaldo M. J. [UNIFESP]Ajzen, Sergio A. [UNIFESP]Higa, Elisa M. S. [UNIFESP]Ronchi, Fernanda A. [UNIFESP]Sesso, Ricardo C. C. [UNIFESP]Casarini, Dulce E. [UNIFESP]Universidade Federal de São Paulo (UNIFESP)2016-01-24T13:51:30Z2016-01-24T13:51:30Z2008-07-01Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 7-8, p. 429-435, 2008.1076-1551http://repositorio.unifesp.br/handle/11600/30750http://dx.doi.org/10.2119/2007-00112.Fernandes10.2119/2007-00112.FernandesWOS:000257727000009The aim of this study was to investigate the association between urinary 90 kDa N-domain Angiotensin I-converting enzyme (ACE) form with C-reactive protein (CRP) and homocysteine plasma levels (Hcy), urinary nitric oxide (NOu), and endothelial function (EF) in normotensive subjects. Forty healthy subjects were evaluated through brachial Doppler US to test the response to reactive hyperemia and a panel of blood tests to determine CRP and Hcy levels, NOu, and urinary ACE. They were divided into groups according to the presence (ACE90+) or absence (ACE90-) of the 90 kDa ACE, the presence (FH+) or absence (FH-) of family history of hypertension, and the presence or absence of these two variables FH+/ACE90+ and FH-/ACE90-. We found an impaired endothelial dilatation in subjects who presented the 90 kDa N-domain ACE as follows: 11.4% +/- 5.3% in ACE90+ compared with 17.6% +/- 7.1% in ACE90- group and 12.4% +/- 5.6% in FH+/ACE90+ compared with 17.7% +/- 6.2% in FH-/ACE90- group, P < 0.05. Hcy and CRP levels were statistically significantly lower in FH+/ACE90+ than in FH-/ACE90- group, as follows: 10.0 +/- 2.3 mu M compared with 12.7 +/- 1.5 mu M, and 1.3 +/- 1.8 mg/L compared with 3.6 +/- 2.0 mg/L, respectively. A correlation between flow-mediated dilatation (FMD) and CRP, Hcy, and NOu levels was not found. Our study suggests a reduction in the basal NO production confirmed by NOu analysis in subjects with the 90 kDa N-domain ACE isoform alone or associated with a family history of hypertension, Our data suggest that the presence of the 90 kDa N-domain ACE itself may have a negative impact on flow-mediated dilatation stimulated by reactive hyperemia.Universidade Federal de São Paulo, Dept Med, Div Nephrol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Image Diagnost, São Paulo, BrazilUniversidade Federal de São Paulo, Oswaldo Ramos Fdn, São Paulo, BrazilUniversidade Federal de São Paulo, Emergency Div, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Med, Div Nephrol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Image Diagnost, São Paulo, BrazilUniversidade Federal de São Paulo, Oswaldo Ramos Fdn, São Paulo, BrazilUniversidade Federal de São Paulo, Emergency Div, São Paulo, BrazilWeb of Science429-435engFeinstein Inst Med ResMolecular MedicineAssociation of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial functioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/307502023-01-12 22:03:33.686metadata only accessoai:repositorio.unifesp.br:11600/30750Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-01-13T01:03:33Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
title Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
spellingShingle Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
Fernandes, Fernanda B. [UNIFESP]
title_short Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
title_full Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
title_fullStr Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
title_full_unstemmed Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
title_sort Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function
author Fernandes, Fernanda B. [UNIFESP]
author_facet Fernandes, Fernanda B. [UNIFESP]
Plavnik, Frida L. [UNIFESP]
Teixeira, Andressa M. S. [UNIFESP]
Christofalo, Dejaldo M. J. [UNIFESP]
Ajzen, Sergio A. [UNIFESP]
Higa, Elisa M. S. [UNIFESP]
Ronchi, Fernanda A. [UNIFESP]
Sesso, Ricardo C. C. [UNIFESP]
Casarini, Dulce E. [UNIFESP]
author_role author
author2 Plavnik, Frida L. [UNIFESP]
Teixeira, Andressa M. S. [UNIFESP]
Christofalo, Dejaldo M. J. [UNIFESP]
Ajzen, Sergio A. [UNIFESP]
Higa, Elisa M. S. [UNIFESP]
Ronchi, Fernanda A. [UNIFESP]
Sesso, Ricardo C. C. [UNIFESP]
Casarini, Dulce E. [UNIFESP]
author2_role author
author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Fernandes, Fernanda B. [UNIFESP]
Plavnik, Frida L. [UNIFESP]
Teixeira, Andressa M. S. [UNIFESP]
Christofalo, Dejaldo M. J. [UNIFESP]
Ajzen, Sergio A. [UNIFESP]
Higa, Elisa M. S. [UNIFESP]
Ronchi, Fernanda A. [UNIFESP]
Sesso, Ricardo C. C. [UNIFESP]
Casarini, Dulce E. [UNIFESP]
description The aim of this study was to investigate the association between urinary 90 kDa N-domain Angiotensin I-converting enzyme (ACE) form with C-reactive protein (CRP) and homocysteine plasma levels (Hcy), urinary nitric oxide (NOu), and endothelial function (EF) in normotensive subjects. Forty healthy subjects were evaluated through brachial Doppler US to test the response to reactive hyperemia and a panel of blood tests to determine CRP and Hcy levels, NOu, and urinary ACE. They were divided into groups according to the presence (ACE90+) or absence (ACE90-) of the 90 kDa ACE, the presence (FH+) or absence (FH-) of family history of hypertension, and the presence or absence of these two variables FH+/ACE90+ and FH-/ACE90-. We found an impaired endothelial dilatation in subjects who presented the 90 kDa N-domain ACE as follows: 11.4% +/- 5.3% in ACE90+ compared with 17.6% +/- 7.1% in ACE90- group and 12.4% +/- 5.6% in FH+/ACE90+ compared with 17.7% +/- 6.2% in FH-/ACE90- group, P < 0.05. Hcy and CRP levels were statistically significantly lower in FH+/ACE90+ than in FH-/ACE90- group, as follows: 10.0 +/- 2.3 mu M compared with 12.7 +/- 1.5 mu M, and 1.3 +/- 1.8 mg/L compared with 3.6 +/- 2.0 mg/L, respectively. A correlation between flow-mediated dilatation (FMD) and CRP, Hcy, and NOu levels was not found. Our study suggests a reduction in the basal NO production confirmed by NOu analysis in subjects with the 90 kDa N-domain ACE isoform alone or associated with a family history of hypertension, Our data suggest that the presence of the 90 kDa N-domain ACE itself may have a negative impact on flow-mediated dilatation stimulated by reactive hyperemia.
publishDate 2008
dc.date.issued.fl_str_mv 2008-07-01
dc.date.accessioned.fl_str_mv 2016-01-24T13:51:30Z
dc.date.available.fl_str_mv 2016-01-24T13:51:30Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 7-8, p. 429-435, 2008.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/30750
http://dx.doi.org/10.2119/2007-00112.Fernandes
dc.identifier.issn.none.fl_str_mv 1076-1551
dc.identifier.doi.none.fl_str_mv 10.2119/2007-00112.Fernandes
dc.identifier.wos.none.fl_str_mv WOS:000257727000009
identifier_str_mv Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 7-8, p. 429-435, 2008.
1076-1551
10.2119/2007-00112.Fernandes
WOS:000257727000009
url http://repositorio.unifesp.br/handle/11600/30750
http://dx.doi.org/10.2119/2007-00112.Fernandes
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Molecular Medicine
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 429-435
dc.publisher.none.fl_str_mv Feinstein Inst Med Res
publisher.none.fl_str_mv Feinstein Inst Med Res
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764121925484544